Skip to content

Safety and Performance of JOURNEY™ II Cruciate Retaining (CR) Total Knee System (TKS)

Safety and Performance of JOURNEY™ II Cruciate Retaining (CR) Total Knee System (TKS): A Retrospective, Multicenter Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03885531
Acronym
JIICR
Enrollment
586
Registered
2019-03-21
Start date
2019-03-27
Completion date
2020-06-30
Last updated
2024-01-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Journey II CR Total Knee System

Keywords

Journey II CR Total Knee System

Brief summary

The objective of this study is to examine the safety and performance of the Journey II CR TKS based on retrospective data.

Interventions

DEVICETotal knee arthroplasty with Journey II CR Total Knee System

TKA with Journey II CR Total Knee System

Sponsors

Nor Consult
CollaboratorUNKNOWN
Smith & Nephew, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL

Inclusion criteria

* Subject received primary uni- or bilateral TKA with the Journey II CR TKS for an approved indication; * The TKA occurred at least 12 weeks prior to enrollment

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frame
Number of adverse events reported per ISO 14155 guidelines7 years

Secondary

MeasureTime frameDescription
Number of hospitalizations (admission for inpatient care) occurring after the hospitalization for the index surgery7 years
Length of stay of hospitalizations (admission for inpatient care) occurring after the hospitalization for the index surgeryupon occurence through 7 years of study duration
Number of rehabilitation sessions7 years
Duration of rehabilitation sessions in weeks7 years
Number and type of outpatient visits7 years
Length of hospital stay for primary (index) surgery7 years
Quality of Life as measured by EQ-5D-3L score7 yearsThe EQ-5D-3L will be collected at each follow up visit. It consists of two pages - the EQ-5D descriptive system (page one) and the EQ visual analogue scale (EQ VAS) (page two). The descriptive system consists of five dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression) each of which takes one of three responses. The responses record three levels of severity (no problems/some or moderate problems/extreme problems) within a particular dimension. The EQ VAS records the respondent's self-rated health on a vertical, visual analogue scale where the endpoints are labelled 'Best imaginable health state' and 'Worst imaginable health state'. This information can be used as a quantitative measure of health outcome as judged by the individual respondents.
Patient Pain Level as measured by Knee Society Score (KSS)7 yearsCombines an objective physician-derived component with a subjective subject-derived component. The objective section rates alignment, instability, joint motion and symptoms. Patient reported expectations and satisfaction questions evaluate pain relief, functional abilities, satisfaction and fulfillment of expectations using a subjective perspective. A functional score is derived from assessments of walking and standing, standard activities, advanced activities and discretionary activities.
Number of days before return to work7 years
Number of technical difficulties encountered with the device7 years
Number of re-operations7 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026